Resolution of the uncertainty of the effects of T-therapy on the male cardiovascular system is important from two perspectives. First, men who are androgen deficient due to diseases of the hypothalamus, pituitary, and testes should be considered for T-replacement therapy.[@ref11] In these men who have hypogonadism due to pathology of the gonadal axis, it is essential to inform and advise them of potential benefits and possible risks of treatment.[@ref12] Second, there has been a marked increase in T prescribing worldwide over the past decades, despite the prevalence of pathological hypogonadism remaining relatively stable.[@ref13][@ref14] In men who do not have hypothalamic, pituitary, or testicular disease, who are typically older with other medical comorbidities and circulating T that would be regarded as low in younger men, the question arises as to the justification for T treatment and whether potential harms might outweigh anticipated benefits.[@ref15] Understanding the extent and the limitations of the existing evidence base would help health practitioners counsel men receiving T treatment for medical indications, may discourage its misuse in men where a medical indication is not clear, and will provide a foundation for future research.

In this Special Issue of the *Asian Journal of Andrology*, authors from around the world provide reviews of the available evidence of the cardiovascular effects of T on men. These reviews cover epidemiological studies of T and the incidence of cardiovascular events[@ref16] and mortality risk,[@ref17] RCTs representing mechanistic studies of T and the cardiovascular system,[@ref18] T RCTs reporting cardiovascular adverse events,[@ref19] and retrospective reviews of T prescription databases.[@ref20] These are accompanied by commentaries on the implications for Andrology in the regional context[@ref21] and globally for studies of male hormonal contraception.[@ref22] Taken together, the content of this Special Issue addresses a pressing debate that affects the care we provide to men with androgen deficiency and future research to preserve health in the expanding population of older men in our communities.
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